Digoxin and its Na

Cancer Cardiovascular diseases Digoxin Mechanisms of action Na(+)/K(+)-ATPase

Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
05 Oct 2024
Historique:
received: 16 08 2024
revised: 27 09 2024
accepted: 01 10 2024
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 13 10 2024
Statut: aheadofprint

Résumé

Na

Identifiants

pubmed: 39396465
pii: S0968-0896(24)00353-5
doi: 10.1016/j.bmc.2024.117939
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117939

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yulin Ren (Y)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States. Electronic address: ren.41@osu.edu.

Andrew T Anderson (AT)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.

Gunnar Meyer (G)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.

Kaitlyn M Lauber (KM)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.

Judith C Gallucci (JC)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.

A Douglas Kinghorn (A)

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States. Electronic address: kinghorn.4@osu.edu.

Classifications MeSH